Advertisement
Journal Home
Search for

Volume 41, Issue 6, Pages 448-450 (December 2009)


View previous. 12 of 24 View next.

Cerebrospinal Fluid Neopterin and Cryopyrin-Associated Periodic Syndrome

Mercedes Serrano, MD, PhDCorresponding Author Informationemail address, Aida Ormazábal, PhD, Jordi Antón, MD, PhD, Juan I. Aróstegui, MD, PhD§, Àngels García-Cazorla, MD, PhD

Received 25 February 2009; accepted 30 June 2009.

Cryopyrin-associated periodic syndrome is a category of autoinflammatory disorders caused by mutations of the NLRP3 gene, with chronic infantile neurologic cutaneous and articular syndrome being the severest clinical phenotype. Various pterins have been reported as mediating immunologic functions in the central nervous system, but to date studies of pterin cerebrospinal fluid (CSF) values and cryopyrin-associated periodic syndrome have been lacking. A 2-year-old child was affected with a severe atypical form of cryopyrin-associated periodic syndrome, suspected based on the analysis of neopterin in CSF. He initially presented isolated neurologic manifestations mimicking a neuroregressive disorder. Blood and CSF analyses did not present any routine inflammatory markers, but CSF neopterin was elevated. Later, the patient developed arthritis and recurrent episodes of fever, and the cryopyrin-associated periodic syndrome diagnosis was confirmed by genetic studies. Neopterin was the most altered indicator over the time. Child neurologists should be on the alert when unexplained neurologic signs appear, giving consideration to the possibility of inflammatory or immune-mediated diseases. The present case demonstrates the clinical utility of measurement of CSF neopterin levels in screening for these immune-mediated diseases, especially when neurologic symptoms are associated with normal results on routine CSF tests.

 Department of Neurology, Hospital “Sant Joan de Déu,” University of Barcelona, Barcelona, Spain

 Department of Clinical Biochemistry, Hospital “Sant Joan de Déu,” University of Barcelona, Barcelona, Spain

 Department of Rheumatology Unit, Hospital “Sant Joan de Déu,” University of Barcelona, Barcelona, Spain

 Center for Biomedical Research on Rare Diseases (CIBERER), Institute of Health “Carlos III,” Barcelona, Spain

§ Department of Immunology, CDB, Hospital Clinic, Clinical Foundation for Biomedical Research, Barcelona, Spain

Corresponding Author InformationCommunications should be addressed to: Dr. Serrano; Pediatric Neurology Department; Hospital Sant Joan de Déu; Passeig de Sant Joan de Déu, 2; 08950 Esplugues de Llobregat; Barcelona, Spain.

PII: S0887-8994(09)00353-1

doi:10.1016/j.pediatrneurol.2009.06.008


View previous. 12 of 24 View next.

Advertisement